Skip to content

AI in Drug Discovery & Development

By Sara Mallatt, Director of Healthcare Research and Sean Carmichael

Hype, Reality, and What Comes Next

IndustryLife Sciences & Healthcare

AI has emerged as a powerful potential solution that could revolutionize how drugs are discovered, developed, and brought to patients. AlphaSense recently hosted an expert call with Dr. Paul Agapow, Former Director of Data Science at GSK, to discuss how AI is making inroads in this area.

Drawing from the call with Dr. Agapow, the latest data, and additional expert insights, this report covers how AI is performing against high expectations, what’s working, and what's not. This report also dissects the competitive arena, covering both today’s key players and the mergers, acquisitions, and collaborations that are defining the future.

About the Authors

  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

  • Sean Carmichael

    Sean is a Business & Finance Editor at AlphaSense, specializing in sector-specific content production. Previously, he spent nearly a decade in various roles across financial services, where he was responsible for equity research and content generation geared toward institutional investors.

Explore more

All articles

Applied AI: Tracking Trends Across Earnings Season

This exclusive resource aggregates insights directly from earnings calls and conference transcripts to benchmark company-specific outcomes and assess where AI investments are translating into operating leverage through 2026 and beyond.
Report
Applied AI: Tracking Trends Across Earnings Season. How companies deploy AI across operations, decisioning, and market development.

Top Market Trends 2026

In this report, we examine the trends and themes shaping 2026, the sector-specific forces driving divergence and opportunity, and the critical inflection points executives and investors must navigate in the year ahead — all based on insights surfaced from across the AlphaSense platform.
Report
Slide titled "Top Market Trends for 2026" listing market intelligence, financial, technology, energy, and healthcare research leaders, with blue line-art icons for science, energy, finance, and media.

Private Equity Distributions: Assessing the Potential Recovery

This report leverages key insights from Seides and those available in AlphaSense to explore the trends shaping the PE landscape heading into 2026.
ReportFinancial Services
Title card for "Private Equity Distributions Assessing the Potential Recovery" with a dollar sign and stacks of cash outlines on a dark background.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.